|
 |
SANGER
The page is no longer available. You may want to read the following pages.
AK Agnihotri... - Archives of Surgery, 2011 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to Cite ULike Add to Connotea Add to Delicious ...
R Lee - Harvard heart letter: from Harvard Medical School, 2011 - ncbi.nlm.nih.gov1. Harv Heart Lett. 2011 Aug;21(12):7. Ask the doctor. I had a heart attack three years
ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol
is 190, and my LDL is 128. Should I be taking a statin? Lee R. ...
R Sakata, Y Fujii... - ... Thoracic and Cardiovascular Surgery, 2011 - Springer The Japanese Association for Thoracic Surgery has conducted annual surveys of thoracic surgery throughout Japan since 1986 to determine the statistics regarding the number of procedures according to the operative category. Here we have summarized the results ...
D Cesselli, AP Beltrami, F D'AURIZIO... - The American journal of ..., 2011 - Rsum/Abstract Currently, it is unknown whether defects in stem cell growth and differentiation contribute to myocardial aging and chronic heart failure (CHF), and whether a compartment of functional human cardiac stem cells (h CSCs) persists in the ...
M Denis, J Marcinkiewicz, A Zaid, D Gauthier... - Circulation, 2012 - Am Heart Assoc BackgroundThe proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes independently of its enzymatic activity the degradation of the LDL receptor (LDLR). PCSK9 gain-of-function in humans leads to autosomal dominant hypercholesterolemia, whereas ...
|
|
|
